Andrew McKibben | Vice President, Investor Relations and Finance |
Chris Peetz | President & Chief Executive Officer |
Peter Radovich | Chief Operating Officer |
Pamela Vig | Head of R&D |
Mani Foroohar | SVB Securities |
Ryan Deschner | Raymond James |
Operator
Ladies and gentlemen, welcome to the Mirum Pharmaceuticals Reports First Quarter 2023 Financial Results and Profile Business Update. My name is Glenn, and I will be the operator for today's call. [Operator Instructions].
I'll now hand over to your host, Andrew McKibben to begin.